Arkolith/Insider Trading/ENDV/Form 4/A

Collier Alan Brian

CEO, DirectorENDONOVO THERAPEUTICS, INC. (ENDV) · full profile →Form 4/A · filed Jan 24, 2020
Net Buying
Open-Market Buys
$150
Open-Market Sells
$0
Net Open-Market Flow
$150
Transactions
7
7 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 20, 2019Buy(P)100$1.50$15026K
Dec 16, 2019Buy(P)500—$025.4M
Dec 12, 2019Buy(P)1K—$025.4M
Dec 11, 2019Buy(P)1K—$025.4M
Dec 11, 2019Buy(P)100—$025.4M
Dec 10, 2019Buy(P)2K—$025.4M
Dec 10, 2019Buy(P)1K—$025.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001645470-20-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML

Keep exploring

Connected pages for ENDONOVO THERAPEUTICS, INC.

Build

Ask your agent about ENDV insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001645470-20-000002"
Ask your agent
Use Arkolith to summarize insider buying and selling at ENDONOVO THERAPEUTICS, INC.
over the last 90 days and cite the filings.